These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21748312)

  • 21. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
    Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
    Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
    Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
    Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.
    Sahu B; Ozturk O; Ranierri M; Serhal P
    Arch Gynecol Obstet; 2008 Mar; 277(3):239-44. PubMed ID: 17899140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.
    Ashrafi M; Hemat M; Arabipoor A; Salman Yazdi R; Bahman-Abadi A; Cheraghi R
    J Obstet Gynaecol; 2017 Jan; 37(1):82-88. PubMed ID: 27976974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the best time to perform intracytoplasmic sperm injection/embryo transfer cycle after hysteroscopic surgery for an incomplete uterine septum?
    Berkkanoglu M; Isikoglu M; Arici F; Ozgur K
    Fertil Steril; 2008 Dec; 90(6):2112-5. PubMed ID: 18177864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Factors related to occurrence of twin pregnancy after double-embryo transfer in vitro fertilization cycles].
    Niu ZH; Feng Y; Zhang AJ; Zhang HQ; Sun YJ; Lu XW
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):413-7. PubMed ID: 19953939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization.
    Takahashi C; Fujito A; Kazuka M; Sugiyama R; Ito H; Isaka K
    Fertil Steril; 2008 Mar; 89(3):586-91. PubMed ID: 17543956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between anti-Müllerian hormone and IVF-ICSI outcome in poor responder patients performing long protocol.
    Aydin T; Kara M; Aran T; Turktekin N; Ozdemir B
    Clin Exp Obstet Gynecol; 2015; 42(5):663-5. PubMed ID: 26524819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram to predict pregnancy rate after ICSI-IVF cycle in patients with endometriosis.
    Ballester M; Oppenheimer A; d'Argent EM; Touboul C; Antoine JM; Coutant C; Daraï E
    Hum Reprod; 2012 Feb; 27(2):451-6. PubMed ID: 22114107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization.
    van der Westerlaken L; Helmerhorst F; Dieben S; Naaktgeboren N
    Fertil Steril; 2005 Mar; 83(3):612-7. PubMed ID: 15749489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome of cycles with oocyte degeneration after intracytoplasmic sperm injection.
    Liu L; Cai J; Li P; Jiang X; Ren J
    Syst Biol Reprod Med; 2017 Apr; 63(2):113-119. PubMed ID: 28151020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.